25-Aug-2016 - The US FDA has warned API manufacturer Unimark Remedies about unsanitary conditions at its facility in Vapi and Bavla in India.
24-Aug-2016 - Pfizer will buy most of AstraZeneca’s antibiotics business in a $1.5bn (€1.32bn) deal that will see the Anglo-Swedish drug firm continue to package Merrem at its Macclesfield, UK plant for at least the next...
23-Aug-2016 - The Eagle is MHI’s Americanized version of its PF-D1S – a compact, servo-driven blister machine, and the company’s first entrance into the North American marketplace.
22-Aug-2016 - Siegfried Holding AG has attributed a surge in API sales to the drug ingredients business it bought from BASF last year, but says that integration costs hurt profits.
18-Aug-2016 - Evolva has agreed to develop new ways of making APIs for an unnamed US biotech using its fermentation system.
17-Aug-2016 - Biomanufacturing demand will drive revenues for Patheon according to an Evercore ISI analyst, who has predicted the newly-listed CDMO will strengthen its capabilities through M&A.
16-Aug-2016 - Ash Stevens has been acquired by Piramal Pharma Solutions, an India-based CDMO, in what the CEO said is an "incredibly powerful combination."
16-Aug-2016 - Drug manufacturers that change hard gelatin capsule suppliers do not need to seek approval beforehand under a policy introduced by the US FDA this week.
16-Aug-2016 - Alcami has announced plans to expand its facilities in Germantown, Wisconsin, in order to increase its Active Pharmaceutical Ingredient (API) production.
16-Aug-2016 - The initiative brought together competing vendors working “side by side,” focusing on a common goal of creating industry-wide standards.
15-Aug-2016 - WuXi AppTec has announced that its Jinshan Shanghai-based small molecule active pharmaceutical ingredient (API) and advanced intermediate manufacturing facility has passed its third US FDA inspection.
11-Aug-2016 - SRF Limited has unveiled plans for a second chloromethane plant just two months after India imposed anti-dumping tariffs on Chinese and Russian imports.
11-Aug-2016 - Arch Biopartners has selected Catalent to carry out studies and make batches of its orphan drug candidate AB569 for upcoming clinical trials.
10-Aug-2016 - Catalent and Zumutor Biologics have combined their technologies to create antibodies with enhanced Antibody Dependent Cellular Cytotoxicity (ADCC) without compromising production levels.
04-Aug-2016 - Antares Vision has developed a new serialization unit in conjunction with the contract manufacturing organization (CMO), PCI Pharma Services.
04-Aug-2016 - Steroid API firm Gadea Pharmaceuticals helped AMRI grow revenue in the second quarter offsetting flat royalties and the impact of the closure of its site in Holywell, Wales.
03-Aug-2016 - The contract research organization (CRO) Velesco Pharma has opened a new laboratory in its Plymouth, MI-based facility to support an increased demand for materials management.
02-Aug-2016 - Keryx Biopharmaceutical's CMO has halted production of Auryxia (ferric citrate) as a results of manufacturing problems.
01-Aug-2016 - Hemispherx Biopharma has hired Avrio Biopharmaceuticals to make Ampligen while it continues to try and win US approval for rejected candidate chronic fatigue syndrome (CFS) drug candidate.
01-Aug-2016 - Regulatory approvals are driving interest in West's Smartdose and Crystal Zenith delivery technologies, the firm says ahead of the launch of a monthly-dose version of Amgen's Repatha.
28-Jul-2016 - Cambrex has said it will invest around $20m in its Pharma 4 API facility before the end of the year in an effort to get ahead of the capacity utilisation curve.
27-Jul-2016 - Symbiosis Pharmaceutical Services is preparing for increasing growth in the outsourcing sector with “a major investment” at its sterile filling facility underway and a recent hire in the US.
27-Jul-2016 - BASF has said it saw lower demand for its remaining active pharmaceutical ingredients (APIs) in the second quarter.
25-Jul-2016 - Acquisitions, higher demand for sterile liquid processing and a surge in Thyrosafe orders helped Recipharm offset pricing pressure in Portugal and lower UK sales in Q2.
21-Jul-2016 - The Medicines Company announced last week that its Angiomax patent has been upheld – an 'important court decision' which affirms that working with CMOs won’t invalidate a company's patent....